Levetiracetam Tablet
Product Images NDC 27808-265

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 27808-265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cranbury Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Formula (Levetiracetam Tablets 1)

Chemical structure of levetiracetam showing its molecular configuration with a pyrrolidone ring, an ethyl group, a carbonyl group, and an amide group, consistent with the active ingredient levetiracetam in the tablet dosage form by Cranbury Pharmaceuticals.*

FDA Label Image

750mg_120 (Levetiracetam Tablets 10)

Label for Levetiracetam tablets, USP 750 mg, oral dosage form. The label includes directions for pharmacists to dispense with a medication guide, dosage information, storage instructions, and manufacturer details. The package contains 120 tablets and is distributed by Tris Pharma, Inc. The label features the NDC 27808-265-01 and a barcode.*

FDA Label Image

1000mg_60 (Levetiracetam Tablets 11)

Levetiracetam Tablets USP 1000 mg oral tablets label displaying the active ingredient strength, dispensing and storage instructions, and pharmacist guidance. The bottle contains 60 tablets. Labeler is Cranbury Pharmaceuticals, LLC, with manufacturing by Zhejiang Jingxin Pharmaceutical Co., Ltd. Barcode and NDC number 27808-266-01 are visible.*

FDA Label Image

Figure 1 (Levetiracetam Tablets 2)

A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The y-axis represents the percentage of patients, with values approximately 7.4%, 37.1%, and 39.6% respectively for each group.*

FDA Label Image

Figure2 (Levetiracetam Tablets 3)

A bar chart showing the percentage of patients across three groups: Placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). The chart compares the effectiveness of Levetiracetam doses to placebo in a patient population with sample sizes indicated for each group.*

FDA Label Image

Figure3 (Levetiracetam Tablets 4)

A bar chart comparing the percentage of patients between two groups: placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The chart indicates 14.4% for placebo and 39.4% for Levetiracetam, with an asterisk marking the higher value for Levetiracetam.*

FDA Label Image

Figure4 (Levetiracetam Tablets 5)

A bar graph comparing the percentage of patients responding to Placebo versus Levetiracetam treatment. The vertical axis shows the percentage of patients, with Placebo at 19.6% (N=97) and Levetiracetam at 44.6% (N=101), highlighting a higher response rate for Levetiracetam.*

FDA Label Image

Figure5 (Levetiracetam Tablets 6)

A bar chart comparing the percentage of patients in two groups: Placebo (N=51) and Levetiracetam (N=58). The chart shows approximately 19.6% for the placebo group and 43.1% for the Levetiracetam group.*

FDA Label Image

Figure6 (Levetiracetam Tablets 7)

A bar graph comparing the percentage of patients in two groups: Placebo and Levetiracetam. The y-axis represents the percentage of patients from 0% to 100%. The Placebo group (N=84) shows about 45.2% of patients, while the Levetiracetam group (N=79) shows about 72.2% of patients. An asterisk marks the Levetiracetam bar.*

FDA Label Image

250mg_120 (Levetiracetam Tablets 8)

Label for Levetiracetam Tablets USP 250 mg oral tablets, containing 120 tablets per bottle. The label includes NDC 27808-263-01, instructions for pharmacists to dispense with a medication guide, and storage instructions. Manufactured by Zhejiang Jingxin Pharmaceutical Co., Ltd. for Tris Pharma, Inc.*

FDA Label Image

500mg_120 (Levetiracetam Tablets 9)

Levetiracetam tablets, USP 500 mg oral tablets packaging label. The label shows a quantity of 120 tablets and includes storage and pharmacist dispensing instructions. The product is labeled under Tris Pharma and includes a barcode. Manufacturer and location details are also provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.